1Ratto GB.Zino P,Mirabelli S,et al.A randomized trial of adoptive immunotherapy with tunor-infiltrating lymphocytes and interleukin-2 versus standard therapy in the postoperative treatment of resected non-small cell lung carcinoma[J]Cancer,1996,78(2) :244- 251.
2Santin AD,Hermonat PL,Ravaggi A,et al .Phenotypic and functional analysis of tumor-infiltrating lymphocytes compared with tumor-associated lymphocytes from ascitic fluid and peripheral blood lymphocytes in patients with advanced ovarian cancer[J] .Gynecol Obstet Invest,2001,51(4) :254- 261.
3Santin AD,Ravaggi A,Bellone S,et al.Tumor-infiltrating 1ymphocytes contain higher numbers of type 1 cytokine expressors and DR + T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix[J] .Gynecol Oncol,2001,81(3) :424 - 432.
4Riemann D,Wenzel K,Schulz T,et al.Phenotypic analysis of T lymphocytes isolated from non-small cell lung cancer[J].Int Arch ALlergy Immunol,1997,11(4) :215- 218.
5Tsunoda T,Tanimura H,Yamaue H,et al.Clonal and functional analysis for the augmentation of tumour -infiltrating lymphocytes by interleukin-4[J] .Br J Cancer,1996,74:1085- 1089.
6Pandolfino MC,Labarriere N,Tessier MH,et al.High-scale expansion of melanoma-reactive TIL by a polyclonal stimulus:predictability and relation with disease advancement[J]Cancer Immunol Immunother,2001,50 (3): 134 - 140.
7Vitolo D,Gallo A,Ciocci L,et al.Interleukin-12 related cytokine gene expression at a tissue level in carcinomas of the larynx[J].Eur Arch Otorhinolaryngol,2000,257(5): 290 -294.
8Godegebuure PS,Douville Lm,Li H,et al.Adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 patients with maligant melanoma and renal cell carcinoma.a pilot study[J] .J Clin Oncol ,1995,13(8):1939.
9Quattrocchi KB,Miller CH,Cush S,et al.Pilot study of local autologous tumor infiltrating lymphocytes for the treatment of recurrent malignant gliomas[J] .Neurooncol,1999,45(2): 141 - 157.
10Ratto GB,Zino P,Mirabelli S,et al.A randomized trial of adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 versus standard therapy in the postoperative treatment of resected non-small cell lung carcinoma[ J ]Cancer,1996,78(2) :244- 251.
